- IRS official refuses to answer questions at scandal hearing
- Bernanke comments spur volatility, but stocks, dollar gain |
- British opposition leader says Google tax behavior 'wrong'
- Senate panel passes immigration bill; Obama praises move
- Rescuers search Oklahoma tornado town ruins as recovery starts |
US approves Glaxo meningitis vaccine for children
WASHINGTON, June 14 |
WASHINGTON, June 14 (Reuters) - U.S. regulators on Thursday approved a new children's vaccine from GlaxoSmithKline PLC that targets two common causes of bacterial meningitis, which can be fatal in children.
The U.S. Food and Drug Administration said the vaccine, Menhibrix, is meant for children aged from 6 weeks to 18 months and targets two types of bacteria that can cause meningitis: meningococcal disease and Hib disease.
- Tweet this
- Share this
- Digg this